US 8962814
Interleukin-1α antibodies and methods of use
granted A61KA61K2039/55527A61K39/3955
Quick answer
US patent 8962814 (Interleukin-1α antibodies and methods of use) held by XBIOTECH INC. expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XBIOTECH INC.
- Grant date
- Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/55527, A61K39/3955, A61P, A61P29/00